(Press-News.org) CLEVELAND—Researchers at Case Western Reserve University and Vanderbilt University are pioneering a new approach to prostate cancer surgery by combining advanced robotics and “low-field” MRI technology.
The research aims to allow highly accurate, patient-tailored prostate cancer surgeries without the need for traditional incisions. This innovative research marks a major step in developing minimally invasive treatments for prostate cancer, with the potential to improve both safety and efficiency for patients.
The project is being funded by a new five-year, $3.7 million grant from the National Cancer Institute, part of the National Institutes of Health (NIH).
William Grissom, the Medtronic Professor of Biomedical Discovery and Innovation at the Case Western Reserve School of Medicine and Case School of Engineering, and Robert Webster, the Richard A. Schroeder Professor of Mechanical Engineering at Vanderbilt University, are leading the collaboration.
Together, they will work to adapt a robot from Virtuoso Surgical Inc. (a Vanderbilt startup company Webster founded) to remove prostate cancer lesions. They will integrate the robot with Promaxo Inc.’s low-field MRI scanner, which, unlike transrectal ultrasound, can image the prostate without blocking surgical access to the lesions.
“Our goal is to eliminate the many complications associated with whole-gland prostate removal to treat prostate cancer,” Grissom said. “Targeted removal of localized prostate lesions could alleviate these complications but is challenging because cancerous tissue can appear identical to healthy tissue in endoscopic images, making accurate surgery difficult.”
Webster added, “The new robot will be able to carefully guide surgical instruments directly to prostate cancer lesions identified in high-field MR images. This will enable surgeons to focus treatment on specific cancerous lesions.”
In addition to securing the NIH grant, Grissom was recently appointed the Case Western Reserve School of Medicine’s first Medtronic Professorship of Biomedical Discovery and Innovation for his transformative work in the field.
###
Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 6,000 undergraduate and 6,300 graduate students comprise our student body. Visit case.edu to see how Case Western Reserve thinks beyond the possible.
Founded in 1873 as an institution that would “contribute to strengthening the ties that should exist between all sections of our common country,” Vanderbilt University is globally renowned for its transformative education and pathbreaking research. The university’s 10 schools reside on a parklike campus set in the heart of Nashville, Tennessee, contributing to a collaborative culture that empowers leaders of tomorrow and prizes free expression, open inquiry and civil discourse.
The Vanderbilt School of Engineering is internationally recognized for the superior quality of its inclusive research and education programs in numerous fields of engineering. The School prepares students to become leaders and innovators in addressing our grand societal challenges.
END
Case Western Reserve, Vanderbilt universities to develop incisionless prostate surgery using MRI and robotics
Awarded five-year, $3.7M grant from National Institutes of Health, National Cancer Institute
2024-10-02
ELSE PRESS RELEASES FROM THIS DATE:
Carnegie Mellon University secures ARPA-H award to improve adherence, lower cost of treatment for obesity and Type 2 diabetes patients
2024-10-02
PITTSBURGH – A Carnegie Mellon University-led team of researchers has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H). The funds will fast track a bioelectronic implant that could radically improve treatment options and significantly reduce the cost of care for patients with obesity and Type 2 diabetes.
The award will drive the accelerated development and testing of “Rx On-site Generation Using Electronics (ROGUE),” a bioelectrical device that hosts a “living pharmacy,” consisting of engineered cells that produce biological therapy to treat Type 2 diabetes and obesity. The device will offer continuous, ...
A new injectable to prevent and treat hypoglycemia
2024-10-02
People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low — from taking too much insulin or not eating enough sugar — people can experience hypoglycemia, which can lead to dizziness, cognitive impairment, seizures or comas. To prevent and treat this condition, researchers in ACS Central Science report encapsulating the hormone glucagon. In mouse trials, the nanocapsules activated when blood sugar levels dropped dangerously low and quickly restored glucose levels.
Glucagon is a hormone that signals the liver to ...
Turning plants into workout supplement bio-factories
2024-10-02
It’s important to eat your veggies, but some essential vitamins and nutrients can only be found in animals, including certain amino acids and peptides. But, in a proof-of-concept study published in ACS’ Journal of Agricultural and Food Chemistry, researchers developed a method to produce creatine, carnosine and taurine — all animal-based nutrients and common workout supplements — right inside a plant. The system allows for different synthetic modules to be easily stacked together to boost production.
Plants can be surprisingly receptive when asked to produce compounds ...
Pablo Manavella appointed next Editor-In-Chief of The Plant Cell
2024-10-02
The American Society of Plant Biologists (ASPB) is excited to announce Pablo Manavella will serve as the next Editor-in-Chief of The Plant Cell. The Plant Cell is a leading international society journal that publishes novel research of special significance in plant biology, especially in the areas of cellular biology, molecular biology, biochemistry, genetics, development, and evolution.
Manavella is currently a Consejo Superior de Investigaciones Científicas (CSIC) researcher at the Institute for Mediterranean and Subtropical Horticulture (IHSM) in Málaga, Spain. He is the Principal Investigator in a lab focusing on the intricate mechanisms regulating ...
Unveiling genetic insights: how PAI-1 polymorphisms influence COVID-19 outcomes
2024-10-02
Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis, which is the process of breaking blood clots, and heightened inflammatory responses. The fibrinolytic system, crucial for maintaining balance within the coagulation cascade, relies on plasmin-mediated fibrin degradation. Plasminogen activators convert plasminogen into plasmin, an enzyme that breaks down ...
Redefining Publishing: PLOS receives multi-million-dollar grant funding for new research initiative
2024-10-02
SAN FRANCISCO —PLOS today announced that it has received a $1.5 million grant from the Robert Wood Johnson Foundation and a $1 million grant from the Gordon and Betty Moore Foundation to support our mission to drive Open Science forward with meaningful change in scholarly publishing. The funds enable PLOS to embark on an ambitious 18-month research and design project to explore how to tackle two barriers that exclude many researchers from meaningfully participating in Open Science: affordability ...
Planning a drug’s route in the body with synthetic chemistry
2024-10-02
Researchers at the RIKEN Cluster for Pioneering Research (CPR) have developed technology that can alter, within the body, the recognized identity of proteins. The innovation, published in Nature Communications on October 2, allowed researchers to target mouse tumors with a protein and then transport that protein out of the body. This means that cancer-killing drugs could be sent directly to tumors and then excreted from the body after dropping off their payload. The technology also has the potential to allow multi-purpose drugs that can travel from organ to organ, performing ...
Smoke from megafires puts orchard trees at risk
2024-10-02
Smoke From Megafires Puts Orchard Trees at Risk
Effects Last Months, Reducing Nut Crop Yields
By Amy Quinton | October 2, 2023
Long-term smoke exposure from massive wildfires lowers the energy reserves of orchard trees and can cut their nut production by half, researchers at the University of California, Davis, found. The smoke can affect trees for months after a megafire, depressing their bloom and the next season’s harvest. This finding reveals a new danger from wildfires that could affect plant health in both agricultural and natural environments.
Nature Plants published ...
Health Data Research UK and National Research Foundation Singapore formalize landmark partnership in health data science
2024-10-02
Health Data Research UK (HDR UK) and the National Research Foundation Singapore (NRF) are pleased to have signed a Memorandum of Understanding (MoU) today, that formalises a collaborative partnership in healthcare and data science. The partnership will leverage cutting-edge data science and research, with a focus on trustworthy data use to power improvements in healthcare, research and innovation, strengthening existing links between the UK and Singapore.
The MoU was signed by Permanent Secretary for National Research and ...
CNIO researchers propose a new treatment for brain metastasis based on immunotherapy
2024-10-02
CNIO researchers have discovered that cancer perverts certain brain cells, the astrocytes, and causes them to produce a protein that works in favour of the tumour.
A drug, silibinin, inhibits this protein, and could be used to help treat brain metastasis with immunotherapy. A clinical trial is underway.
The work is published in the American Association for Cancer Research's journal Cancer Discovery.
Researchers at the Spanish National Cancer Research Centre (CNIO) propose a new treatment for brain metastases that respond poorly, or not at all, to immunotherapy, and provide a biomarker to predict ...
LAST 30 PRESS RELEASES:
Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes
Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease
Five University of Tennessee faculty receive Fulbright Awards
5 advances to protect water sources, availability
OU Scholar awarded Fulbright for Soviet cinema research
Brain might become target of new type 1 diabetes treatments
‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts
Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes
Study reveals hidden drivers of asthma flare-ups in children
Physicists decode mysterious membrane behavior
New insights about brain receptor may pave way for next-gen mental health drugs
Melanoma ‘sat-nav’ discovery could help curb metastasis
When immune commanders misfire: new insights into rheumatoid arthritis inflammation
SFU researchers develop a new tool that brings blender-like lighting control to any photograph
Pups in tow, Yellowstone-area wolves trek long distances to stay near prey
AI breakthrough unlocks 'new' materials to replace lithium-ion batteries
Making molecules make sense: A regional explanation method reveals structure–property relationships
Partisan hostility, not just policy, drives U.S. protests
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025
Young human blood serum factors show potential to rejuvenate skin through bone marrow
Large language models reshape the future of task planning
Narrower coverage of MS drugs tied to higher relapse risk
Researchers harness AI-powered protein design to enhance T-cell based immunotherapies
Smartphone engagement during school hours among US youths
Online reviews of health care facilities
MS may begin far earlier than previously thought
New AI tool learns to read medical images with far less data
Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025
Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025
Reporting guideline for chatbot health advice studies
[Press-News.org] Case Western Reserve, Vanderbilt universities to develop incisionless prostate surgery using MRI and roboticsAwarded five-year, $3.7M grant from National Institutes of Health, National Cancer Institute